Indo-MIM IPO Registers 1.4x Subscription on Day Two; Analysts Affirm Strong Global Growth Trajectory

Indo-MIM IPO Registers 1.4x Subscription on Day Two; Analysts Affirm Strong Global Growth Trajectory​

Indo-MIM Ltd.'s massive Rs 3,811.21-crore initial public offering (IPO) continues to demonstrate robust market interest following a strong performance on the second day of bidding. As of midday trading, the issue was subscribed at 1.40 times, reflecting the enthusiasm among prospective investors for the precision manufacturing giant.

The IPO sought bids for 5.50 crore shares, and the successful subscription signifies high demand in the market. Non-institutional investors (NIIs) were particularly enthusiastic participants, with their reserved portion receiving a impressive subscription rate of 3.85 times. Retail and employee categories also showed solid interest, with retail segments subscribed at 1.04 times.

Investor Sentiment and Market Valuation​

The Grey Market Premium (GMP) suggests that Indo-MIM's shares are potentially poised to list around Rs 650 per share. This estimated price implies a potential listing gain of approximately 34% over the upper issue price of Rs 485. It is crucial, however, for investors to remember that GMP represents unofficial sentiment and should not be viewed as a guarantee of eventual listing returns.

SBI Securities has highlighted Indo-MIM's solid positioning within the global Metal Injection Molding (MIM) industry. The brokerage noted the company held a 6.8% global market share in CY25, underscoring its stature in specialized manufacturing. At the upper price band of Rs 485 per share, the IPO is valued at 38.4 times its FY26 earnings.

Financial Health and Business Diversification​

Financially, Indo-MIM reported significant growth in FY26, demonstrating increasing revenue and profitability. Total income rose 28.1% year-on-year to Rs 4,320.70 crore from Rs 3,373.97 crore recorded in FY25. Furthermore, profit after tax (PAT) surged by 25.9%, reaching Rs 533.54 crore in FY26 from Rs 423.73 crore the previous year.

The company's diversified operations are key to its future prospects. Indo-MIM serves crucial sectors including automotive, defence, medical, consumer goods, and aerospace. Its manufacturing capabilities span mold design, tooling, machining, finishing, and assembly. This breadth allows the company to cater effectively across various high-demand global markets.

Global Manufacturing Footprint and Operational Scale​

Established in 1996, Indo-MIM Ltd. operates as a major international manufacturer of precision engineering components using advanced MIM technology. The firm possesses the world's largest installed Metal Injection Molding (MIM) capacity globally. It has successfully expanded beyond core MIM into technologies such as investment casting, ceramic injection molding, and 3D metal printing.

Indo-MIM maintains an extensive global presence with 15 manufacturing facilities strategically located across India, the United States, the United Kingdom, and Mexico. The company's international reach is supported by sales offices in China, Germany, and the US, serving over 1,100 customers worldwide during FY26.

IPO Structure and Proceeds Allocation​

The book-built issue comprises a fresh issuance of 1.03 crore equity shares valued at Rs 499.10 crore. The remaining portion is an offer-for-sale (OFS) totaling 6.83 crore equity shares, valued at Rs 3,311.21 crore by existing shareholders. This constitutes the full issue size of Rs 3,811.21 crore.

The public subscription period commenced on July 23 and runs until July 27, 2026. The price band is set between Rs 461 and Rs 485 per share. Investors can begin bidding with a minimum of 30 shares, which translates to an investment of at least Rs 14,550 at the upper limit of the price band.

Indo-MIM has committed Rs 400 crore from the net IPO proceeds toward the repayment or prepayment of certain outstanding borrowings. The remainder of the funds will be allocated for general corporate purposes. HDFC Bank and Axis Capital among others are serving as book-running lead managers for the issue.